Eris Lifesciences Limited — Others, 06-03-2025: ESOP/ESOS/ESPS

Eris Lifesciences has announced a board meeting to discuss the allotment of 33,287 equity shares under the ESOP-2021 scheme. The breakdown includes 7,530 shares from 2022 at ₹557.24 each, 14,074 shares from 2023 at ₹510.32 each, and 11,683 shares from 2024 at ₹728.16 each. Following this allotment, the company's paid-up share capital rises to ₹13,61,62,569. This move reflects the company's commitment to incentivize employee retention and motivation. Investors may view this as a positive initiative, indicating potential growth and employee engagement in the company's strategy.